|
rs798766
|
|
|
0.770 |
GeneticVariation |
BEFREE |
rs798766 is associated with increased risk of bladder cancer, and no ethnic difference was found.
|
28655970 |
2017 |
|
rs1051740
|
|
|
0.010 |
GeneticVariation |
BEFREE |
A comprehensive systematic review and meta-analysis was performed of available studies on these two polymorphisms and cancer risk published up to November 2010, consisting of 84 studies (31144 cases and 42439 controls) for Tyr113His and 77 studies (28496 cases and 38506 controls) for His139Arg primarily focused on lung cancer, upper aerodigestive tract (UADT) cancers (including oral, pharynx, larynx and esophagus cancers), colorectal cancer or adenoma, bladder cancer and breast cancer.
|
21445251 |
2011 |
|
rs2234922
|
|
|
0.010 |
GeneticVariation |
BEFREE |
A comprehensive systematic review and meta-analysis was performed of available studies on these two polymorphisms and cancer risk published up to November 2010, consisting of 84 studies (31144 cases and 42439 controls) for Tyr113His and 77 studies (28496 cases and 38506 controls) for His139Arg primarily focused on lung cancer, upper aerodigestive tract (UADT) cancers (including oral, pharynx, larynx and esophagus cancers), colorectal cancer or adenoma, bladder cancer and breast cancer.
|
21445251 |
2011 |
|
rs10775480
|
|
|
0.710 |
GeneticVariation |
GWASDB |
A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3.
|
21824976 |
2011 |
|
rs7238033
|
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3.
|
21824976 |
2011 |
|
rs2228001
|
|
|
0.100 |
GeneticVariation |
BEFREE |
A meta-analysis was performed to examine the association between XPC Lys939Gln polymorphism and susceptibility to bladder cancer (BC).
|
23269608 |
2013 |
|
rs2294008
|
|
T |
0.800 |
GeneticVariation |
GWASDB |
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.
|
20972438 |
2010 |
|
rs798766
|
|
T |
0.770 |
GeneticVariation |
GWASDB |
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.
|
20972438 |
2010 |
|
rs9642880
|
|
T |
0.760 |
GeneticVariation |
GWASDB |
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.
|
20972438 |
2010 |
|
rs710521
|
|
A |
0.740 |
GeneticVariation |
GWASDB |
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.
|
20972438 |
2010 |
|
rs1495741
|
|
|
0.720 |
GeneticVariation |
GWASDB |
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.
|
20972438 |
2010 |
|
rs401681
|
|
C |
0.710 |
GeneticVariation |
GWASDB |
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.
|
20972438 |
2010 |
|
rs9642880
|
|
T |
0.760 |
GeneticVariation |
GWASDB |
A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.
|
20348956 |
2010 |
|
rs710521
|
|
A |
0.740 |
GeneticVariation |
GWASDB |
A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.
|
20348956 |
2010 |
|
rs1799983
|
|
|
0.030 |
GeneticVariation |
BEFREE |
A significant association for NOS3 Glu298Asp heterozygotes genotypes and T allely were found between healthy controls and bladder cancer, respectively (p<0.001: p=0.002).
|
23621215 |
2013 |
|
rs1800371
|
|
|
0.020 |
GeneticVariation |
BEFREE |
A significant association was found with p53 codon 248 polymorphism and BC risk whereas p53 codon 11 and p53 Pro47Ser polymorphism showed no association with BC risk.
|
22101376 |
2011 |
|
rs2839698
|
|
|
0.010 |
GeneticVariation |
BEFREE |
A significantly decreased risk of bladder cancer was found for the rs2839698 TC genotype (odds ratio [OR], 0.60; 95% confidence interval (95%CI), 0.36-0.99), but not for CC homozygotes.
|
18262338 |
2008 |
|
rs9642880
|
|
|
0.760 |
GeneticVariation |
BEFREE |
A single nucleotide polymorphism of MYC rs9642880 (G>T) at the 8q24.1 locus is thought to be associated with bladder cancer risk based on the results of genome-wide association studies, but the results remain inconclusive.
|
26600535 |
2015 |
|
rs16901904
|
|
|
0.010 |
GeneticVariation |
BEFREE |
A two-stage case-control study was conducted to assess the association between four tagging SNPs (i.e., rs4871771, rs1902432, rs16901904 and rs710886) and bladder cancer risk.
|
28627442 |
2017 |
|
rs2295080
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Additionally, mTOR rs2295080 variant notably increased the risk of BC (OR=2.25, 95 % CI=1.50-3.38, p<0.0001, GT vs GG; OR=4.75, 95 % CI=2.80-8.06, p<0.0001, TT vs GG; OR=3.10, 95 % CI=2.34-4.10, p<0.0001, T vs G).
|
29383014 |
2018 |
|
rs709816
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Additionally, positive associations were found for rs709816 with bladder cancer (OR(adj) = 4.2, 95% CI: 1.4, 12) and rs1063054 with lung cancer (OR(adj) = 1.6, 95% CI: 1.0, 2.3).
|
20478923 |
2010 |
|
rs1063054
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Additionally, positive associations were found for rs709816 with bladder cancer (OR(adj) = 4.2, 95% CI: 1.4, 12) and rs1063054 with lung cancer (OR(adj) = 1.6, 95% CI: 1.0, 2.3).
|
20478923 |
2010 |
|
rs1799864
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Additionally, the combination of CCR2 V64I and CCR5 Δ32 (i.e., GG-wt/Δ32) was found to be associated with BC risk.
|
22982413 |
2012 |
|
rs763059810
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Additionally, the combination of CCR2 V64I and CCR5 Δ32 (i.e., GG-wt/Δ32) was found to be associated with BC risk.
|
22982413 |
2012 |
|
rs1799793
|
|
|
0.080 |
GeneticVariation |
BEFREE |
Among four DNA repair gene polymorphisms, the OGG1 326 Ser/Cys and XPD 312 Asp/Asn heterozygous genotypes might be recognized as potential genetic markers modifying susceptibility to bladder cancer in Belarus.
|
25089939 |
2014 |